Invesco Ltd. Vaxxinity, Inc. Transaction History

Invesco Ltd.

  • $460 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$0.62 - $0.86 $102 - $141
-165 Reduced 0.87%
18,756 $13,000
Q4 2023

Feb 12, 2024
SELL
$0.7 - $1.31 $1,987 - $3,720
-2,840 Reduced 13.05%
18,921 $16,000
Q2 2023

Aug 11, 2023
BUY
$1.73 - $2.79 $37,646 - $60,713
21,761 New
21,761 $54,000

Others Institutions Holding VAXX

# of Institutions
9
Shares Held
469K
Call Options Held
0
Put Options Held
0
View Full List

About Vaxxinity, Inc.

VAXX Quotes by TradingView
  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Market Cap $1.12M
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email